Close Menu

NEW YORK – Thermo Fisher Scientific said on Wednesday that it has acquired cell sorting technology assets from biotech instrumentation company Propel Labs, a wholly owned subsidiary of Sidis that is based in Fort Collins, Colorado.

Under the agreement, Propel Labs' Bigfoot Spectral Cell Sorter technology is becoming part of Thermo Fisher's Biosciences business in its Life Sciences Solutions segment. Thermo Fisher will also take on approximately 40 employees from Propel Labs, which will continue as a separate entity and still serve existing customers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.